Resistance to ICT has also been attributed to tumour downregulation of β2M, an essential component of MHC class I antigen presentation, suggesting that deficiency in antigen presentation to CD8 + T cells is another form of ICT resistance [56]. The gene discussed is B2M; the disease is neoplasm.